Mono-(2-ethylhexyl) phthalate (MEHP) regulates glucocorticoid metabolism through 11β-hydroxysteroid dehydrogenase 2 in murine gonadotrope cells

Biochemical and Biophysical Research Communications

Volumn 389, Issue 2, 2009, Pages 305-309

  Hong, Dun ^a,b   Li, Xing Wang ^a,c   Lian, Qing Quan ^c   Lamba, Pankaj ^d   Bernard, Daniel J ^d   Hardy, Dianne O ^a   Chen, Hai Xiao ^b   Ge, Ren Shan ^a  

^a POPULATION COUNCIL   (United States)

^b TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

11 HSD2; Glucocorticoids; Gonadotrope; Metabolism; Mono (2 ethylhexyl) phthalate

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MIFEPRISTONE; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENITAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CELL LINE; CELL PROLIFERATION; CORTICOSTERONE; DIETHYLHEXYL PHTHALATE; GLUCOCORTICOIDS; GONADOTROPHS; MICE;

MURINAE;

EID: 70349333524     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.134     Document Type: Article

References (30)

1. Waring R.H., and Harris R.M. Endocrine disrupters: a human risk?. Mol. Cell. Endocrinol. 244 (2005) 2-9
2. Ge R.S., Chen G.R., Dong Q., Akingbemi B., Sottas C.M., Santos M., Sealfon S.C., Bernard D.J., and Hardy M.P. Biphasic effects of postnatal exposure to diethylhexylphthalate on the timing of puberty in male rats. J. Androl. 28 (2007) 513-520
3. Plonait S.L., Nau H., Maier R.F., Wittfoht W., and Obladen M. Exposure of newborn infants to di-(2-ethylhexyl)-phthalate and 2-ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters. Transfusion 33 (1993) 598-605
4. Takatori S., Okamoto Y., Kitagawa Y., Hori S., Izumi S., Makino T., and Nakazawa H. Simulated neonatal exposure to DEHP and MEHP from PVC enteral nutrition products. Int. J. Pharm. 352 (2008) 139-145
5. Song X.F., Wei G.H., Liu X., Zhang D.Y., Chen X., and Deng Y.J. Effects of diethylhexyl phthalate (DEHP) on INSL3 mRNA expression by Leydig cells derived from mouse embryos and in newborn mice. J. Int. Med. Res. 36 (2008) 512-521
6. Andrade A.J., Grande S.W., Talsness C.E., Gericke C., Grote K., Golombiewski A., Sterner-Kock A., and Chahoud I. A dose response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): reproductive effects on adult male offspring rats. Toxicology 228 (2006) 85-97
7. Gray Jr. L.E., Ostby J., Furr J., Price M., Veeramachaneni D.N., and Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol. Sci. 58 (2000) 350-365
8. Agarwal D.K., Maronpot R.R., Lamb J.C.T., and Kluwe W.M. Adverse effects of butyl benzyl phthalate on the reproductive and hematopoietic systems of male rats. Toxicology 35 (1985) 189-206
9. Davis B.J., Maronpot R.R., and Heindel J.J. Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol. Appl. Pharmacol. 128 (1994) 216-223
10. Lee K.Y., Shibutani M., Takagi H., Kato N., Takigami S., Uneyama C., and Hirose M. Diverse developmental toxicity of di-n-butyl phthalate in both sexes of rat offspring after maternal exposure during the period from late gestation through lactation. Toxicology 203 (2004) 221-238
11. Akingbemi B.T., Ge R., Klinefelter G.R., Zirkin B.R., and Hardy M.P. Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc. Natl. Acad. Sci. USA 101 (2004) 775-780
12. Akingbemi B.T., Youker R.T., Sottas C.M., Ge R., Katz E., Klinefelter G.R., Zirkin B.R., and Hardy M.P. Modulation of rat Leydig cell steroidogenic function by di(2-ethylhexyl)phthalate. Biol. Reprod. 65 (2001) 1252-1259
13. Supornsilchai V., Soder O., and Svechnikov K. Stimulation of the pituitary-adrenal axis and of adrenocortical steroidogenesis ex vivo by administration of di-2-ethylhexyl phthalate to prepubertal male rats. J. Endocrinol. 192 (2007) 33-39
14. Kim H.S., Ishizaka M., Kazusaka A., and Fujita S. Di-(2-ethylhexyl) phthalate suppresses tamoxifen-induced apoptosis in GH3 pituitary cells. Arch. Toxicol. 81 (2007) 27-33
15. Albro P.W. Absorption, metabolism, and excretion of di(2-ethylhexyl) phthalate by rats and mice. Environ. Health Perspect. 65 (1986) 293-298
16. Huber W.W., Grasl-Kraupp B., and Schulte-Hermann R. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit. Rev. Toxicol. 26 (1996) 365-481
17. McGillivray S.M., Thackray V.G., Coss D., and Mellon P.L. Activin and glucocorticoids synergistically activate follicle-stimulating hormone beta-subunit gene expression in the immortalized LbetaT2 gonadotrope cell line. Endocrinology 148 (2007) 762-773
18. Thackray V.G., McGillivray S.M., and Mellon P.L. Androgens, progestins, and glucocorticoids induce follicle-stimulating hormone beta-subunit gene expression at the level of the gonadotrope. Mol. Endocrinol. 20 (2006) 2062-2079
19. McAndrews J.M., Ringstrom S.J., Dahl K.D., and Schwartz N.B. Corticosterone in vivo increases pituitary follicle-stimulating hormone (FSH)-beta messenger ribonucleic acid content and serum FSH bioactivity selectively in female rats. Endocrinology 134 (1994) 158-163
20. Schreihofer D.A., Stoler M.H., and Shupnik M.A. Differential expression and regulation of estrogen receptors (ERs) in rat pituitary and cell lines: estrogen decreases ERalpha protein and estrogen responsiveness. Endocrinology 141 (2000) 2174-2184
21. Lawson M.A., Li D., Glidewell-Kenney C.A., and Lopez F.J. Androgen responsiveness of the pituitary gonadotrope cell line LbetaT2. J. Endocrinol. 170 (2001) 601-607
22. Tomlinson J.W., Walker E.A., Bujalska I.J., Draper N., Lavery G.G., Cooper M.S., Hewison M., and Stewart P.M. 11beta-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr. Rev. 25 (2004) 831-866
23. White P.C., Mune T., and Agarwal A.K. 11beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev. 18 (1997) 135-156
24. Ge R.S., Gao H.B., Nacharaju V.L., Gunsalus G.L., and Hardy M.P. Identification of a kinetically distinct activity of 11beta-hydroxysteroid dehydrogenase in rat Leydig cells. Endocrinology 138 (1997) 2435-2442
25. Monder C., and Lakshmi V. Corticosteroid 11beta-dehydrogenase of rat tissues: immunological studies. Endocrinology 126 (1990) 2435-2443
26. Ge R.S., Dong Q., Niu E.M., Sottas C.M., Hardy D.O., Catterall J.F., Latif S.A., Morris D.J., and Hardy M.P. 11{beta}-Hydroxysteroid dehydrogenase 2 in rat leydig cells: its role in blunting glucocorticoid action at physiological levels of substrate. Endocrinology 146 (2005) 2657-2664
27. Lakshmi V., and Monder C. Purification and characterization of the corticosteroid 11beta-dehydrogenase component of the rat liver 11beta-hydroxysteroid dehydrogenase complex. Endocrinology 123 (1988) 2390-2398
28. Sang G.W., Lorenzo B., and Reidenberg M.M. Inhibitory effects of gossypol on corticosteroid 11-beta-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia. J. Steroid Biochem. Mol. Biol. 39 (1991) 169-176
29. Berger S.A., Cole T.J., Schmid W., and Schutz G. Molecular genetic analysis of glucocorticoid and mineralocorticoid signaling in development and physiological processes. Steroids 61 (1996) 236-239
30. Vacchio M.S., Papadopoulos V., and Ashwell J.D. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179 (1994) 1835-1846